N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors

Milan Bruncko1, Stephen K Tahir, Xiaohong Song

  • 1Cancer Research, Global Pharmaceutical R&D, Abbott Laboratories, Abbott Park, IL 60064-6101, USA. milan.bruncko@abbott.com